GERM
Amplify Treatments, Testing and Advancements ETF
GERM
GERM
Delisted
GERM was delisted on the 5th of September, 2024.
24 hedge funds and large institutions have $6M invested in Amplify Treatments, Testing and Advancements ETF in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 1 closing their positions.
Holders
24
Holders Change
+2
Holders Change %
+9.09%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$1.45M |
| 2 |
2
Jane Street
New York
|
$265K |
| 3 |
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$1.1M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$865K |
| 5 |
5
Osaic Holdings
Scottsdale,
Arizona
|
$172K |
